Keratitis-Ichthyosis-Deafness Syndrome Overview
Learn About Keratitis-Ichthyosis-Deafness Syndrome
Keratitis-ichthyosis-deafness (KID) syndrome is characterized by eye problems, skin abnormalities, and hearing loss.
KID syndrome is caused by mutations in the GJB2 gene. This gene provides instructions for making a protein called gap junction beta 2, more commonly known as connexin 26. Connexin 26 is a member of the connexin protein family. Connexin proteins form channels called gap junctions that permit the transport of nutrients, charged atoms (ions), and signaling molecules between neighboring cells that are in contact with each other. Gap junctions made with connexin 26 transport potassium ions and certain small molecules.
KID syndrome is a rare disorder. Its prevalence is unknown. Approximately 100 cases have been reported.
KID syndrome is usually inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In some cases, an affected person inherits the mutation from one affected parent. However, most cases result from new mutations in the gene and occur in people with no history of the disorder in their family.
Yale University
Keith Choate is a Dermatologist in New Haven, Connecticut. Dr. Choate is rated as an Advanced provider by MediFind in the treatment of Keratitis-Ichthyosis-Deafness Syndrome. His top areas of expertise are Nonbullous Congenital Ichthyosiform Erythroderma, Darier Disease, Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limbs Defects, and Lamellar Ichthyosis.
Dolehide Dermatology, SC
Conor Dolehide is a Dermatologist in Oak Lawn, Illinois. Dr. Dolehide is rated as a Distinguished provider by MediFind in the treatment of Keratitis-Ichthyosis-Deafness Syndrome. His top areas of expertise are Netherton Syndrome, Ichthyosis Bullosa of Siemens, Peeling Skin Syndrome, and Keratitis-Ichthyosis-Deafness Syndrome.
Isaac Garcia practices in Valparaiso, Chile. Mr. Garcia is rated as a Distinguished expert by MediFind in the treatment of Keratitis-Ichthyosis-Deafness Syndrome. His top areas of expertise are DFNB1, Keratitis-Ichthyosis-Deafness Syndrome, Interstitial Keratitis, and Hearing Loss.
Published Date: November 01, 2012
Published By: National Institutes of Health
